MRX LIQ 0.2 %
BENZOIC ACID : 0.2 % ALCOHOL ANHYDROUS : 40 % BENZETHONIUM CHLORIDE : 0.13 % CAMPHOR : 0.7 % · DIN 00430765 · MAHDEEN MEDICEUTICALS, DIVISION OF ZERON INC.
Health Canada status: CANCELLED POST MARKET
What is MRX LIQ?
MRX LIQ 0.2 % contains BENZOIC ACID : 0.2 % ALCOHOL ANHYDROUS : 40 % BENZETHONIUM CHLORIDE : 0.13 % CAMPHOR : 0.7 %. It is listed in the Health Canada Drug Product Database under DIN 00430765, held by MAHDEEN MEDICEUTICALS, DIVISION OF ZERON INC., supplied as LIQUID for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 12-Feb-2002. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00430765 |
|---|---|
| Brand name | MRX LIQ |
| Generic / active ingredient | BENZOIC ACID : 0.2 % ALCOHOL ANHYDROUS : 40 % BENZETHONIUM CHLORIDE : 0.13 % CAMPHOR : 0.7 % |
| Manufacturer | MAHDEEN MEDICEUTICALS, DIVISION OF ZERON INC. |
| Strength | 0.2 % |
| Dosage form | LIQUID |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D08AJ58 BENZETHONIUM CHLORIDE, COMBINATIONS |
| AHFS class | 84:04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 12-Feb-2002 |
| Original market date | 1972-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D08AJ58 BENZETHONIUM CHLORIDE, COMBINATIONS. 0 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ANTISEPTIC SKIN CREAM | 2000 UNIT | CREAM | ARJO CANADA INC | CANCELLED POST MARKET | DIN 01988158 |
| BURO SOL ANTISEPTIC POWDER | 0.35 % | POWDER | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 00579947 |
| LIPSOREX | 0.26 % | GEL | CANDERM G.P. | CANCELLED POST MARKET | DIN 02237806 |
| LIPSOREX - GEL | 0.9 % | GEL | VEXCO LABORATORIES INC. | CANCELLED POST MARKET | DIN 02122006 |
| LIPSOREX-GEL | 0.9 % | GEL | VEXCO LABORATORIES INC. | CANCELLED POST MARKET | DIN 02138239 |
| MARCORODEX | 1 G / 100 ML | LIQUID | ROUGIER PHARMA DIVISION OF RATIOPHARM INC | CANCELLED POST MARKET | DIN 02229710 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.